Bortezomib enhances antigen-specific cytotoxic T cell responses against immune-resistant cancer cells generated by STAT3-ablated dendritic cells.
第一作者:
Jee-Eun,Kim
第一单位:
Department of Anatomy, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
作者:
主题词
动物(Animals);细胞凋亡(Apoptosis);硼酸化物(Boronic Acids);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);癌症疫苗(Cancer Vaccines);细胞系, 肿瘤(Cell Line, Tumor);树突细胞(Dendritic Cells);减量调节(Down-Regulation);女(雌)性(Female);基因缺失(Gene Deletion);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);模型, 分子(Models, Molecular);肿瘤(Neoplasms);吡嗪类(Pyrazines);STAT3转录因子(STAT3 Transcription Factor);T淋巴细胞, 细胞毒性(T-Lymphocytes, Cytotoxic);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53)
DOI
10.1016/j.phrs.2013.02.001
PMID
23428347
发布时间
2021-10-21
- 浏览2
Pharmacological research
23-33页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文